3-189665394-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003722.5(TP63):c.62+33817C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 151,848 control chromosomes in the GnomAD database, including 11,408 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.38 ( 11408 hom., cov: 32)
Consequence
TP63
NM_003722.5 intron
NM_003722.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.152
Publications
60 publications found
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
- ADULT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- ankyloblepharon-ectodermal defects-cleft lip/palate syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- limb-mammary syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- Rapp-Hodgkin syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- premature ovarian failure 21Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- split hand-foot malformation 4Inheritance: AD Classification: MODERATE Submitted by: Illumina
- EEC syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- split hand-foot malformationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.429 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TP63 | NM_003722.5 | c.62+33817C>T | intron_variant | Intron 1 of 13 | ENST00000264731.8 | NP_003713.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.379 AC: 57464AN: 151732Hom.: 11405 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
57464
AN:
151732
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.379 AC: 57498AN: 151848Hom.: 11408 Cov.: 32 AF XY: 0.376 AC XY: 27927AN XY: 74176 show subpopulations
GnomAD4 genome
AF:
AC:
57498
AN:
151848
Hom.:
Cov.:
32
AF XY:
AC XY:
27927
AN XY:
74176
show subpopulations
African (AFR)
AF:
AC:
12404
AN:
41438
American (AMR)
AF:
AC:
4766
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
AC:
1417
AN:
3464
East Asian (EAS)
AF:
AC:
1551
AN:
5144
South Asian (SAS)
AF:
AC:
1580
AN:
4806
European-Finnish (FIN)
AF:
AC:
4986
AN:
10532
Middle Eastern (MID)
AF:
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29453
AN:
67928
Other (OTH)
AF:
AC:
765
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1821
3641
5462
7282
9103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1145
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.